FI3999180T3 - (r)-n-(5-(5-etyyli-1,2,4-oksadiatsol-3-yyli)-2,3-dihydro-1h-inden-1–yyli)-1–metyyli-1h-pyratsoli-4-karboksamidin polymorfeja - Google Patents
(r)-n-(5-(5-etyyli-1,2,4-oksadiatsol-3-yyli)-2,3-dihydro-1h-inden-1–yyli)-1–metyyli-1h-pyratsoli-4-karboksamidin polymorfeja Download PDFInfo
- Publication number
- FI3999180T3 FI3999180T3 FIEP20753562.6T FI20753562T FI3999180T3 FI 3999180 T3 FI3999180 T3 FI 3999180T3 FI 20753562 T FI20753562 T FI 20753562T FI 3999180 T3 FI3999180 T3 FI 3999180T3
- Authority
- FI
- Finland
- Prior art keywords
- polymorph
- polymorphic form
- peaks
- degrees
- xrpd pattern
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962875350P | 2019-07-17 | 2019-07-17 | |
| PCT/US2020/042387 WO2021011807A1 (en) | 2019-07-17 | 2020-07-16 | Polymorphs of (r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3999180T3 true FI3999180T3 (fi) | 2024-06-18 |
Family
ID=71995103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP20753562.6T FI3999180T3 (fi) | 2019-07-17 | 2020-07-16 | (r)-n-(5-(5-etyyli-1,2,4-oksadiatsol-3-yyli)-2,3-dihydro-1h-inden-1–yyli)-1–metyyli-1h-pyratsoli-4-karboksamidin polymorfeja |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20220315571A1 (https=) |
| EP (2) | EP3999180B1 (https=) |
| JP (2) | JP7624431B2 (https=) |
| KR (1) | KR20220084008A (https=) |
| CN (3) | CN114555590B (https=) |
| AU (1) | AU2020313965A1 (https=) |
| BR (1) | BR112022000494A2 (https=) |
| CA (1) | CA3144975A1 (https=) |
| CL (1) | CL2022000054A1 (https=) |
| DK (1) | DK3999180T3 (https=) |
| ES (1) | ES2980885T3 (https=) |
| FI (1) | FI3999180T3 (https=) |
| HR (1) | HRP20240713T1 (https=) |
| HU (1) | HUE066891T2 (https=) |
| IL (1) | IL289875A (https=) |
| LT (1) | LT3999180T (https=) |
| MX (1) | MX2022000504A (https=) |
| PH (1) | PH12022550123A1 (https=) |
| PL (1) | PL3999180T3 (https=) |
| PT (1) | PT3999180T (https=) |
| RS (1) | RS65611B1 (https=) |
| SI (1) | SI3999180T1 (https=) |
| SM (1) | SMT202400224T1 (https=) |
| TW (1) | TWI865562B (https=) |
| WO (1) | WO2021011807A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019144041A1 (en) | 2018-01-19 | 2019-07-25 | Cytokinetics, Inc. | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors |
| JP7610985B2 (ja) | 2018-06-26 | 2025-01-09 | サイトキネティックス， インコーポレイテッド | 心臓サルコメア阻害剤 |
| JP7438148B2 (ja) | 2018-06-26 | 2024-02-26 | サイトキネティックス， インコーポレイテッド | 心臓サルコメア阻害剤 |
| MA53491A (fr) | 2018-08-31 | 2021-09-15 | Cytokinetics Inc | Inhibiteurs de sarcomes cardiaques |
| CN117083275A (zh) | 2021-03-04 | 2023-11-17 | 赛特凯恩蒂克公司 | 心脏肌节抑制剂 |
| PT4370116T (pt) | 2021-07-16 | 2025-03-14 | Cytokinetics Inc | Regimes de administração de aficamten para o tratamento da cardiomiopatia hipertrófica obstrutiva |
| MX2024001294A (es) | 2021-08-03 | 2024-02-13 | Cytokinetics Inc | Proceso para la preparacion de aficamten. |
| WO2024020468A1 (en) | 2022-07-20 | 2024-01-25 | Cytokinetics, Incorporated | Methods for treating non-obstructive hypertrophic cardiomyopathy |
| EP4565230A1 (en) | 2022-08-04 | 2025-06-11 | Cytokinetics, Inc. | Methods for treating obstructive hypertrophic cardiomyopathy |
| WO2024134498A1 (en) | 2022-12-22 | 2024-06-27 | Assia Chemical Industries Ltd. | Solid state forms of aficamten and process for preparation thereof |
| WO2024179422A1 (zh) * | 2023-03-02 | 2024-09-06 | 苏州科睿思制药有限公司 | Aficamten的共晶及其制备方法和用途 |
| US20250295639A1 (en) | 2024-03-20 | 2025-09-25 | Cytokinetics, Incorporated | Methods for treating heart diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019144041A1 (en) | 2018-01-19 | 2019-07-25 | Cytokinetics, Inc. | Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors |
| MX2024001294A (es) * | 2021-08-03 | 2024-02-13 | Cytokinetics Inc | Proceso para la preparacion de aficamten. |
-
2020
- 2020-07-16 EP EP20753562.6A patent/EP3999180B1/en active Active
- 2020-07-16 CN CN202080059660.0A patent/CN114555590B/zh active Active
- 2020-07-16 DK DK20753562.6T patent/DK3999180T3/da active
- 2020-07-16 CN CN202411172321.XA patent/CN119119018A/zh active Pending
- 2020-07-16 ES ES20753562T patent/ES2980885T3/es active Active
- 2020-07-16 PT PT207535626T patent/PT3999180T/pt unknown
- 2020-07-16 RS RS20240598A patent/RS65611B1/sr unknown
- 2020-07-16 MX MX2022000504A patent/MX2022000504A/es unknown
- 2020-07-16 SM SM20240224T patent/SMT202400224T1/it unknown
- 2020-07-16 PL PL20753562.6T patent/PL3999180T3/pl unknown
- 2020-07-16 LT LTEPPCT/US2020/042387T patent/LT3999180T/lt unknown
- 2020-07-16 SI SI202030443T patent/SI3999180T1/sl unknown
- 2020-07-16 PH PH1/2022/550123A patent/PH12022550123A1/en unknown
- 2020-07-16 WO PCT/US2020/042387 patent/WO2021011807A1/en not_active Ceased
- 2020-07-16 CA CA3144975A patent/CA3144975A1/en active Pending
- 2020-07-16 HR HRP20240713TT patent/HRP20240713T1/hr unknown
- 2020-07-16 US US17/627,599 patent/US20220315571A1/en active Pending
- 2020-07-16 EP EP24174636.1A patent/EP4487911A1/en active Pending
- 2020-07-16 KR KR1020227004639A patent/KR20220084008A/ko active Pending
- 2020-07-16 HU HUE20753562A patent/HUE066891T2/hu unknown
- 2020-07-16 BR BR112022000494A patent/BR112022000494A2/pt unknown
- 2020-07-16 JP JP2022502215A patent/JP7624431B2/ja active Active
- 2020-07-16 AU AU2020313965A patent/AU2020313965A1/en active Pending
- 2020-07-16 TW TW109124093A patent/TWI865562B/zh active
- 2020-07-16 CN CN202411172308.4A patent/CN118908951A/zh active Pending
- 2020-07-16 FI FIEP20753562.6T patent/FI3999180T3/fi active
-
2022
- 2022-01-10 CL CL2022000054A patent/CL2022000054A1/es unknown
- 2022-01-16 IL IL289875A patent/IL289875A/en unknown
-
2025
- 2025-01-20 JP JP2025007662A patent/JP7755090B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3999180T3 (fi) | (r)-n-(5-(5-etyyli-1,2,4-oksadiatsol-3-yyli)-2,3-dihydro-1h-inden-1–yyli)-1–metyyli-1h-pyratsoli-4-karboksamidin polymorfeja | |
| JP2022540668A5 (https=) | ||
| TWI313264B (en) | Triamide-substituted heterobicyclic compounds | |
| HK1244694A1 (zh) | 新颖的胰高血糖素受体拮抗剂 | |
| JPH08508034A (ja) | フェノキシフェニル酢酸誘導体 | |
| JPWO2001064670A1 (ja) | 新規環状アミド誘導体 | |
| CN102448937A (zh) | 作为钙或钠通道阻滞剂的芳基取代羧酰胺衍生物 | |
| TWI600658B (zh) | 醛固酮合成酶抑制劑 | |
| WO2007129745A1 (ja) | ヘテロアリールアミド低級カルボン酸誘導体 | |
| JP2004043453A (ja) | （ｓ）−４−アミノ−５−クロロ−２−メトキシ−ｎ−［１−［１−（２−テトラヒドロフリルカルボニル）−４−ピペリジニルメチル］−４−ピペリジニル］ベンズアミド、その製造方法、それを含有する医薬組成物及び該化合物の中間体 | |
| EP3053916A1 (en) | Compound having agonistic activity to somatostatin receptor and medicinal use thereof | |
| WO2019121611A1 (en) | Substituted pyrrolidine amides ii | |
| WO2019196714A1 (zh) | 作为dhodh抑制剂的n-取代丙烯酰胺衍生物及其制备和用途 | |
| JPH01294675A (ja) | １，４−ジヒドロピリジン誘導体、これらの製造法およびこれらの薬剤としての適用 | |
| WO2008050732A1 (fr) | Dérivé de l'iminopyridine et son utilisation | |
| JP2022542803A5 (https=) | ||
| CA2903180A1 (en) | 3,4-dihydro-2h-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds | |
| TWI331142B (https=) | ||
| JP4511184B2 (ja) | オキシトシン・アンタゴニストとしてのトリアゾール類 | |
| KR20100042671A (ko) | 신규 페닐아세테이트 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 ｔ-형 칼슘 이온 채널의 활성에 의해 유발되는 질환의 예방 또는 치료용 조성물 | |
| CA3008698C (en) | Ginkgolide b derivative and preparation method and use thereof | |
| JP2004525132A (ja) | オキシトシン調節活性を有するピロリジンエステル誘導体 | |
| JP2005526816A (ja) | 抗ヒスタミン薬および抗アレルギー薬としてのアザインドリルピペリジン誘導体 | |
| KR100470075B1 (ko) | 1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물 | |
| JP6199902B2 (ja) | イミダゾリルケトン誘導体ａｓｄアルドステロン合成酵素阻害剤 |